Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PGK1 | P00558 | 1/20 | 0.50 |
| ▸ | PGK2 | P07205 | 1/20 | 0.50 |
| ▸ | PGD | P52209 | 3/20 | 0.47 |
| ▸ | MPI | P34949 | 1/20 | 0.47 |
| ▸ | LPAR5 | Q9H1C0 | 2/20 | 0.46 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.44 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.43 |
| ▸ | LMNA | P02545 | 1/20 | 0.43 |
| ▸ | LPAR1 | Q92633 | 2/20 | 0.42 |
| ▸ | LPAR6 | P43657 | 1/20 | 0.42 |
| ▸ | LPAR4 | Q99677 | 1/20 | 0.42 |
| ▸ | LPAR2 | Q9HBW0 | 1/20 | 0.42 |
| ▸ | LPAR3 | Q9UBY5 | 1/20 | 0.42 |
| ▸ | ENPP2 | Q13822 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Glycerin SCHEMBL28247436 | 0.98 | PGK1 (0.48) | PGK1PGK2PGDMPILPAR5 | |
| SCHEMBL14278848 | 0.98 | PGK1 (0.52) | PGK1PGK2PGDMPILPAR5 | |
| SCHEMBL6655023 | 0.98 | PGK1 (0.52) | PGK1PGK2PGDMPILPAR5 | |
| SCHEMBL7341 | 0.98 | PGK1 (0.52) | PGK1PGK2PGDMPILPAR5 | |
| SCHEMBL7340 | 0.98 | PGK1 (0.52) | PGK1PGK2PGDMPILPAR5 | |
| SCHEMBL14278847 | 0.98 | PGK1 (0.52) | PGK1PGK2PGDMPILPAR5 | |
| SCHEMBL213379 | 0.98 | PGK1 (0.52) | PGK1PGK2PGDMPILPAR5 | |
| SCHEMBL1134754 | 0.95 | PGK1 (0.50) | PGK1PGK2PGDMPILPAR5 | |
| Selenium SCHEMBL7630839 | 0.95 | PGK1 (0.50) | PGK1PGK2PGDMPILPAR5 | |
| SCHEMBL11313373 | 0.95 | PGK1 (0.50) | PGK1PGK2PGDMPILPAR5 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 26 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-5869525-A | DRUG FOR INTRACEREBRAL ADMINISTRATION HAVING GOOD PERMEABILITY THROUGH A BLOOD BRAINBARRIER AND HIGH INTRACEREBRAL ACTIVITY | SHOWA DENKO KABUSHIKI KAISHA (JP) | 1999-02-09 | — | — | US | claimed |
| CN-109890832-B | Semi-biosynthetic production of fatty alcohols and fatty aldehydes | 普罗维维股份有限公司 | 2022-08-12 | — | — | CN | disclosed |
| CN-110191755-A | Particle shape composition, liquid composition, the manufacturing method of particle shape composition, surface modifier, the method for improving water dispersible | 学校法人神奈川大学 | 2019-08-30 | — | — | CN | disclosed |
| CN-105142681-B | Semi-fluorocarbon containing contrast agents | 贝朗医疗有限公司 | 2019-03-12 | — | — | CN | disclosed |
| CN-104367997-B | Adjunvant composition comprising nonionic isotonic agent | 葛兰素史密丝克莱恩生物有限公司 | 2019-01-22 | — | — | CN | disclosed |
| CN-108853520-A | A kind of quick type lipid nano particle of sound, using and preparation method thereof | 重庆医科大学 | 2018-11-23 | — | — | CN | disclosed |
| CN-108348894-A | Ozonolysis for compound activation and ozonolysis | 空气交叉股份有限公司 | 2018-07-31 | — | — | CN | disclosed |
| CN-104878044-B | A kind of lipoid substance siRNA transfection reagents | 常州百代生物科技有限公司 | 2018-07-17 | — | — | CN | disclosed |
| CN-104959052-B | The method for synthesizing membrane vesicle for preparing major diameter | 帕西拉制药有限公司 | 2018-07-13 | — | — | CN | disclosed |
| CN-104427976-B | Hydrophobic depot formulations of active ingredient and preparation method thereof | 佩因拉佛姆有限公司 | 2018-04-24 | — | — | CN | disclosed |
| CN-106456546-A | Liposomal compositions for mucosal delivery | 葛兰素史密丝克莱恩生物有限公司 | 2017-02-22 | — | — | CN | disclosed |
| CN-106456545-A | Immunogenic liposomal formulation | 葛兰素史密丝克莱恩生物有限公司 | 2017-02-22 | — | — | CN | disclosed |
| CN-105263896-A | Conversion of free fatty acids to ethyl esters | AURORA BIOFUELS INC | 2016-01-20 | — | — | CN | disclosed |
| CN-105209600-A | Methods for regulating nitrogen metabolism during the production of ethanol from corn by metabolically engineered yeast strains | LALLEMAND HUNGARY LIQUIDITY MAN LLC | 2015-12-30 | — | — | CN | disclosed |
| CN-105121637-A | An electron consuming ethanol production pathway to displace glycerol formation in s. cerevisiae | LALLEMAND HUNGARY LIQUIDITY MAN LLC | 2015-12-02 | — | — | CN | disclosed |
| US-8168417-B2 | Bacillus licheniformis chromosome | NOVOZYMES A/S (DK) | 2012-05-01 | — | — | US | disclosed |
| US-20120070881-A1 | Bacillus licheniformis chromosome | NOVOZYMES A/S (DK) | 2012-03-22 | — | — | US | disclosed |
| US-20110086407-A1 | Bacillus licheniformis chromosome | NOVOZYMES A/S (DK) | 2011-04-14 | — | — | US | disclosed |
| US-5869525-A | DRUG FOR INTRACEREBRAL ADMINISTRATION HAVING GOOD PERMEABILITY THROUGH A BLOOD BRAINBARRIER AND HIGH INTRACEREBRAL ACTIVITY | SHOWA DENKO KABUSHIKI KAISHA (JP) | 1999-02-09 | — | — | US | disclosed |
| US-5204242-A | Coupling component for colorimetric analysis of detection of oxidative coupling reaction; peroxide or peroxidase or aromatic amine detection | BOEHRINGER MANNHEIM GMBH (DE) | 1993-04-20 | — | — | US | disclosed |